Clinical Trial Update: Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gefitinib with or without chemotherapy in brain metastases from non-small cell lung cancer is ongoing; results not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer, Brain Metastases | Phase 3 | Status: UNKNOWN